The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer.
Villanueva L, Silva L, Llopiz D, Ruiz M, Iglesias T, Lozano T, Casares N, Hervas-Stubbs S, Rodríguez MJ, Carrascosa JL, Lasarte JJ, Sarobe P.
Villanueva L, et al. Among authors: iglesias t.
Oncoimmunology. 2017 Dec 21;7(4):e1409321. doi: 10.1080/2162402X.2017.1409321. eCollection 2018.
Oncoimmunology. 2017.
PMID: 29632721
Free PMC article.